论文部分内容阅读
上海交大昂立股份有限公司(股票代码:600530)是集现代生物和医药制品研制、生产、营销于一体的高科技股份制企业,由上海交通大学、上海大众交通(集团)股份有限公司等九家股东单位于1997年共同发起设立,注册资金1.5亿元。2001年7月成为国内保健品行业中第一家上市公司,注册资金增至2亿元,净资产增至9亿元。公司实行现代企业管理制度,在松江拥有符合GMP规范的生产基地,并已通过ISO9001国际质量管理体系认证。公司遵循以技术为依托、以产品为载体、以科普为先导、以营销为龙头的发展战略,形成了强有力的全国营销网络。目前,新加坡、香港等东南亚市场销售已具规模,并已拓展美国和日本等国际市场。
Shanghai Jiao Tong University Co., Ltd. (stock code: 600530) is a high-tech joint-stock enterprise that integrates the development, production and marketing of modern biological and medical products. Shanghai Jiao Tong University, Shanghai Volkswagen Transportation (Group) Co., Ltd., Shareholder units co-sponsored the establishment in 1997 with a registered capital of 150 million yuan. July 2001 became the first listed company in the domestic health care products industry, the registered capital increased to 200 million yuan, the net assets increased to 900 million yuan. Companies implementing modern enterprise management system, in Songjiang has a GMP-compliant production base, and has passed the ISO9001 international quality management system certification. Companies follow the technology as the basis, product as a carrier, science as the guide, marketing as the leading development strategy, formed a strong national marketing network. At present, sales in Southeast Asia such as Singapore and Hong Kong are already large-scale and have expanded the international markets such as the United States and Japan.